How Much Muscle Do You Lose on Semaglutide or Tirzepatide?

"You lose muscle, not just fat, on a GLP-1" gets repeated so often it has become a cliché — but it is also true, and the trials now have the DXA scans to quantify it precisely. Here is what the actual body-composition data shows, and what is genuinely within your control.

The actual numbers, from a real body-composition substudy

A formal body-composition substudy of SURMOUNT-1 — using dual-energy X-ray absorptiometry (DXA), the clinical standard for measuring fat versus lean tissue — found that of the total weight lost on tirzepatide, roughly a quarter came from lean mass, with the remainder from fat mass². A separate 2024 systematic review focused specifically on semaglutide's effect on lean mass across its clinical trials found a broadly similar pattern: a meaningful share of total weight loss is lean tissue, even though fat loss makes up the clear majority¹. A 2025 network meta-analysis comparing body-composition outcomes across GLP-1 receptor agonists and dual agonists found this lean-mass loss is a consistent feature of the drug class generally, not an outlier specific to one molecule³.

Is that actually abnormal?

Not entirely — this is worth stating plainly rather than treating GLP-1s as uniquely destructive to muscle. Any method of significant weight loss, including calorie restriction alone and bariatric surgery, results in some proportion of lean mass loss alongside fat loss; the body does not lose exclusively fat regardless of how the deficit is created. What the GLP-1 data adds is precision — we now have DXA-confirmed numbers for these specific drugs rather than an assumption borrowed from other weight-loss methods. The practical takeaway is not that GLP-1s are unusually dangerous to muscle, but that the lean-mass share of the loss is real, measurable, and — this is the part worth acting on — at least partially something you can influence.

What actually protects lean mass — and what doesn't have strong evidence yet

**Resistance training has the strongest rationale**, even though it was not the primary focus of either pivotal trial. The physiological logic is well-established independent of GLP-1s: muscle tissue responds to mechanical load, and skipping resistance exercise during any significant calorie deficit removes the main stimulus telling your body to preserve it. If you are on a GLP-1 and not doing any resistance training, this is the single highest-leverage change available to you.

**Protein intake matters for the same reason.** Adequate protein — particularly with appetite substantially suppressed, when it becomes easy to under-eat protein simply because you are not hungry enough to prioritize it — supports muscle preservation during a calorie deficit generally. Because a GLP-1 can suppress appetite enough that hitting a protein target takes deliberate effort rather than happening naturally, this is worth planning for rather than assuming will take care of itself.

**Titration pace is a secondary lever.** Slower, label-consistent dose escalation produces a slower rate of total weight loss, which — by the same logic that governs "Ozempic face" and skin retraction — may give the body more opportunity to preserve lean tissue relative to a faster loss, though this specific link has not been directly isolated in a trial the way the fat/lean split itself has. Our titration planner shows the labeled escalation schedule if you want to check your pace.

What this does not mean

It does not mean the weight-loss benefit is illusory, or that the drugs are secretly "just" causing muscle wasting — roughly three-quarters or more of the total weight lost is fat, by the substudy's own numbers², and the cardiometabolic benefits demonstrated across the STEP and SURMOUNT trial programs are real and substantial. It does mean that "just take the drug and do nothing else" leaves real, measurable lean mass on the table that a resistance-training and protein-intake plan can partially protect.

Where this fits into your bigger plan

This is not something a provider prescribes for you directly — it is a lifestyle factor you control in parallel with the medication. But a provider with genuine ongoing support, rather than a checkout-and-done model, is more likely to actually coach you toward it, which is part of why member support is a scored factor in our Verdict Score methodology. Compare providers on that basis in the ranked reviews, and if you are still weighing which molecule to start on, see how semaglutide and tirzepatide actually compare for the fuller trade-off.

This is editorial information, not medical advice. Talk to your prescriber or a registered dietitian before making significant changes to your protein intake or exercise routine.